Ninepoint Cannabis & Alternative Health Series F (NPP5421)
10.24
+0.09
(+0.86%)
CAD |
Dec 30 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.58% | 11.41M | 0.51% | 8.29% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 8.757M | 5.70% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund's objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions (including cannabis). |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Biotechnology |
| Peer Group | Sector Equity |
| Global Macro | Equity Industry Sector |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Ninepoint Partners |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
42
-22.90M
Peer Group Low
148.72M
Peer Group High
1 Year
% Rank:
35
8.757M
-357.30M
Peer Group Low
560.91M
Peer Group High
3 Months
% Rank:
33
-70.79M
Peer Group Low
300.57M
Peer Group High
3 Years
% Rank:
44
-877.11M
Peer Group Low
1.081B
Peer Group High
6 Months
% Rank:
29
-133.13M
Peer Group Low
293.50M
Peer Group High
5 Years
% Rank:
59
-338.29M
Peer Group Low
1.371B
Peer Group High
YTD
% Rank:
--
-276.55M
Peer Group Low
509.27M
Peer Group High
10 Years
% Rank:
77
-187.16M
Peer Group Low
1.837B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 31, 2025.
*Indicates data for the year is incomplete.
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 4.18% |
| Stock | 85.26% |
| Bond | 7.64% |
| Convertible | 0.00% |
| Preferred | 2.93% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Green Thumb Industries, Inc. | 13.57% | 8.036 | -0.29% |
| Costco Wholesale Corp. | 8.17% | 862.27 | -0.39% |
|
Icanic Brands Co Inc FRN 09-Sep-2027
|
7.64% | -- | -- |
| Cronos Group, Inc. | 6.12% | 2.635 | 0.57% |
| Microsoft Corp. | 5.67% | 483.55 | -0.81% |
| Trulieve Cannabis Corp. | 5.16% | 8.69 | -1.03% |
| Amazon.com, Inc. | 4.77% | 230.79 | -0.75% |
| Glass House Brands, Inc. | 4.18% | 8.84 | -1.67% |
|
USD Cash
|
3.96% | -- | -- |
| Quest Diagnostics, Inc. | 3.87% | 173.45 | -1.16% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP |
|
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund's objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions (including cannabis). |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Biotechnology |
| Peer Group | Sector Equity |
| Global Macro | Equity Industry Sector |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Ninepoint Partners |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (12-30-25) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 44 |
| Stock | |
| Weighted Average PE Ratio | 33.75 |
| Weighted Average Price to Sales Ratio | 6.203 |
| Weighted Average Price to Book Ratio | 4.920 |
| Weighted Median ROE | -58.58% |
| Weighted Median ROA | -0.28% |
| ROI (TTM) | -4.02% |
| Return on Investment (TTM) | -4.02% |
| Earning Yield | 0.0333 |
| LT Debt / Shareholders Equity | 0.3488 |
| Number of Equity Holdings | 36 |
| Bond | |
| Yield to Maturity (11-30-25) | -- |
| Effective Duration | -- |
| Average Coupon | -- |
| Calculated Average Quality | -- |
| Effective Maturity | -- |
| Nominal Maturity | -- |
| Number of Bond Holdings | 1 |
As of November 30, 2025
Growth Metrics
| EPS Growth (1Y) | 47.94% |
| EPS Growth (3Y) | 1.17% |
| EPS Growth (5Y) | 0.33% |
| Sales Growth (1Y) | 11.10% |
| Sales Growth (3Y) | 10.81% |
| Sales Growth (5Y) | 26.98% |
| Sales per Share Growth (1Y) | 16.14% |
| Sales per Share Growth (3Y) | 7.53% |
| Operating Cash Flow - Growth Rate (3Y) | 24.93% |
As of November 30, 2025
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:NPP5421.TO", "name") |
| Broad Asset Class: =YCI("M:NPP5421.TO", "broad_asset_class") |
| Broad Category: =YCI("M:NPP5421.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:NPP5421.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |